Literature DB >> 12888877

Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder.

Prameet M Sheth1, Walter H A Kahr, M Anwar Haq, Dragoslava Kika Veljkovic, Georges E Rivard, Catherine P M Hayward.   

Abstract

The Quebec Platelet Disorder (QPD) is an unusual bleeding disorder associated with increased platelet stores of urokinase-type plasminogen activator (u-PA) and proteolysis of platelet alpha-granule proteins. The increased u-PA and proteolyzed plasminogen in QPD platelets led us to investigate possible contributions of intracellular plasmin generation to QPD alpha-granule proteolysis. ELISA indicated there were normal amounts of plasminogen and plasmin-alpha(2)-antiplasmin (PAP) complexes in QPD plasmas. Like normal platelets, QPD platelets contained only a small proportion of the blood plasminogen, however, they contained an increased amount of PAP complexes compared to normal platelets (P < 0.005). The quantities of plasminogen stored in platelets were important to induce QPD-like proteolysis of normal alpha-granule proteins by two chain u-PA (tcu-PA) in vitro. Moreover, adding supplemental plasminogen to QPD, but not to control, platelet lysates, triggered further alpha-granule protein proteolysis to forms that comigrated with plasmin degraded proteins. These data suggest the generation of increased but limiting amounts of plasmin within platelets is involved in producing the unique phenotypic changes to alpha-granule proteins in QPD platelets. The QPD is the only known bleeding disorder associated with chronic, intracellular activation of the fibrinolytic cascade.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888877     DOI: 10.1160/TH02-12-0323

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis.

Authors:  Denisa Urban; Ling Li; Hilary Christensen; Fred G Pluthero; Shao Zun Chen; Michael Puhacz; Parvesh M Garg; Kiran K Lanka; James J Cummings; Helmut Kramer; James D Wasmuth; John Parkinson; Walter H A Kahr
Journal:  Blood       Date:  2012-09-21       Impact factor: 22.113

2.  Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation.

Authors:  D Kika Veljkovic; Georges E Rivard; Maria Diamandis; Jessica Blavignac; Elisabeth M Cramer-Bordé; Catherine P M Hayward
Journal:  Blood       Date:  2008-11-24       Impact factor: 22.113

3.  The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes.

Authors:  Catherine P M Hayward; Minggao Liang; Subia Tasneem; Asim Soomro; John S Waye; Andrew D Paterson; Georges E Rivard; Michael D Wilson
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

4.  Thrombin generation abnormalities in Quebec platelet disorder.

Authors:  Justin G Brunet; Tanmya Sharma; Subia Tasneem; Minggao Liang; Michael D Wilson; Georges E Rivard; Catherine P M Hayward
Journal:  Int J Lab Hematol       Date:  2020-08-06       Impact factor: 2.877

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.